Regeneron Soars 5%: Can an Old Blockbuster Drug’s New Chapter Restore Investor Confidence? Dec 1, 2025 Life Science
The “Set-and-Forget” Strategy: 3 Canadian Dividend Stocks to Buy for the Long Haul Nov 30, 2025 Consumer Goods, Energy, Technology
Seeking Lifelong Passive Income? 2 Top-Tier TSX Dividend Stocks to Consider Nov 26, 2025 Consumer Goods, Energy
Novartis Soars on New Drug Approval, But Its Long-Term Investment Case Runs Much Deeper Nov 26, 2025 Life Science
The Ultimate Dividend Kings List: Building a Steady Income Portfolio Nov 25, 2025 Consumer Goods, Technology
Seeking Shelter in Stocks: Why This Restaurant Giant Is a Top Defensive Pick Nov 24, 2025 Consumer Goods
Aging Population, Growing Opportunity: A Guide to Investing in Healthcare REITs Nov 23, 2025 Life Science, Real Estate
Building Your Passive Income Engine: A Beginner’s Blueprint for Stock Market Dividends Nov 23, 2025 Energy, Financial Service, Real Estate
Defying Falling Oil Prices, This Canadian Energy Stock Has Risen 70% in Seven Months Nov 19, 2025 Energy
Dividend Kings Expand to 56 Members, Healthcare Sector Contributes Four Resilient Players Nov 18, 2025 Life Science
Laurentian Bank: An Overlooked Canadian Banking Stock Poised for a Turnaround Nov 17, 2025 Financial Service
